Diets containing soy protein isolate increase hepatic CYP3A expression and inducibility in weanling male rats exposed during early development

Journal of Nutrition

Volumn 134, Issue 12, 2004, Pages 3270-3276

  Ronis, Martin J ^a,b   Chen, Ying ^a,b   Jo, Chan He ^b   Simpson, Pippa ^b   Badger, Thomas M ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

CYP3A; Development; Induction; Rats; Soy protein isolate

Indexed keywords

6BETA HYDROXYTESTOSTERONE; CASEIN; CLOTRIMAZOLE; CORN OIL; CYTOCHROME P450 3A; DEXAMETHASONE; MESSENGER RNA; MIDAZOLAM; SOYBEAN PROTEIN; TESTOSTERONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DEVELOPMENT; INTRON; LIVER MICROSOME; MALE; NONHUMAN; NORTHERN BLOTTING; PROTEIN DIET; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; WEANING;

ANIMALIA; GLYCINE MAX; STAPHYLOCOCCUS PHAGE 3A; ZEA MAYS;

EID: 10044248605     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.12.3270     Document Type: Conference Paper

References (53)

1. Ronis, M.J.J. & Ingelman-Sundberg, M. (1998) Induction of human P450 enzymes: mechanisms and implications. In: A Handbook of Human Toxicology (Woolf, T., ed.), pp. 239-262. Marcel Decker, New York, NY.
2. Westlind-Johansson, A., Malmenbo, S., Johansson, A., Otter, C., Andersson, T. B., Johansson, I., Edwards, R. J., Boobis, A. R. & Ingelman-Sundberg, M. (2003) Comparative analysis of CYP3A expression in human liver suggest only a minor role for CYP3A5 in drug metabolism. Drug Metab. Disp. 31: 755-761.
3. Scheutz, E. G., Beach, D. L. & Guzelian, P. S. (1994) Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4: 11-20.
4. Wilkinson, G. R. (1996) Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans. J. Pharmacokinet. Biopharm. 24: 475-490.
5. Kanamori, M., Takahashi, H. & Echizen, H. (2002) Developmental changes in the liver weight and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children. Int. J. Clin. Pharmacol. Ther. 40: 485-489.
6. Stevens, J. C., Hines, R. N., Gu, C., Koukouritaki, S. B., Manro, J. R., Tandler, P. J. & Zaya, M. J. (2003) Developmental expression of the major human hepatic CYP3A enzymes. J. Pharmcol. Exp. Ther. 307: 573-582.
7. Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J. & Evans, R. M. (2001) An essential role for nuclear receptors SXR/RXR in detoxification of cholestatic bile acids. Proc. Natl. Acad. Sci. U.S.A. 98: 3375-3380.
8. Badawi, A. F., Cavalieri, E. L. & Rogan, E. G. (2001) Role of human cytochrome P450 1A1, 1A2, 1B1 and 3A4 in the 2-, 4- and 16α-hydroxylation of 17β-estradiol. Metabolism 50: 1001-1003.
9. Lee, A. J., Cal, M. X., Thomas, P. E., Conney, A. H. & Zhu, B. T. (2003) Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology 144: 3382-3398.
10. Van Vleet, T. R., Kleain, P. J. & Coulombe, R. A., Jr. (2002) Metabolism and cytotoxicity of aflatoxin B1 in cytochrome P450-expressing human lung cells. J. Toxicol Environ. Health 65A: 853-867.
11. Yamazaki, H., Inui, Y., Wrighton, S. A., Guengerich, F. P. & Shimada, T. (1995) Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis 16: 2167-2170.
12. Zheng, W., Jin, F., Dunning, L. A., Shu X. O., Dai, O., Wen, W. O., Gao, Y. T. & Holtzman, J. L. (2001) Epidemiological study of urinary 6β-hydroxy-cortisol to cortisol ratios and breast cancer risk. Cancer Epidemiol. Biomark. Prev. 10: 237-242.
13. Dome, J. L., Walton, K. & Renwick, A. G. (2003) Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. Food Chem. Toxicol. 41: 201-224.
14. Matsumura, K., Saito, T., Takahashi, Y., Ozeki, T., Kiyotani, K., Fujieda, M., Yamazaki, H., Kunitoh, H. & Kamataki, T. (2004) Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol. Pharmacol. 65: 326-334.
15. Harris, R. Z., Jang, G. R. and Tsunoda, S. (2003) Dietary effects on drug metabolism and transport. Clin. Pharmacokinet. 42: 1071-1088.
16. Bailey, D. G., Malcolm, J., Arnold, O. & Spence, J. D. (1998) Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol. 46: 101-110.
17. Ronis, M.J.J., Rowlands, J. C., Hakkak, H. & Badger, T. M. (1999) Altered enzyme expression and glucocorticoid-inducibility of hepatic CYP3A and CYP2B enzymes in male rats fed diets containing soy protein isolate. J. Nutr. 129: 1958-1965.
18. Setchell, K. D., Zimmer-Nechemias, L., Cai, J. & Heubi, J. E. (1997) Exposure of infants to phytoestrogens from soy-based infant formula. Lancet 350: 23-27.
19. Mahnke, A., Strotkamp, D., Roos, P. H., Hanstein, W. G., Chabot, G. G. & Nef, P. (1997) Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch. Biochem. Biophys. 337: 62-68.
20. Wright, M. C., Edwards, R. J., Pimenta, M., Ribeiro, V., Lechner, M. C. & Paine, A. J. (1997) Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2. Biochem. Pharmacol. 54: 841-846.
21. Lacroix, D., Sonnier, M., Moncion, A., Cheron, G. & Cresteil, T. (1997) Expression of CYP3A in human liver - evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur. J. Biochem. 247: 625-634.
22. Pereira, T. M. & Lechner, M. C. (1995) Differential regulation of the cytochrome P450 CYP3A1 gene transcription by dexamethasone in immature and adult rat liver. Eur. J. Biochem. 229: 171-177.
23. Eliasson, E., Mkrtchian, S., Halpert, J. & Ingelman-Sundberg, M. (1994) Substrate-regulated, cAMP-dependent phosphorylation, denaturation and degradation of glucocorticoid-inducible rat liver cytochrome P450 3A1. J. Biol. Chem. 269: 18378-18383.
24. Wang, H., Kawashima, H. & Strobel, H. W. (1997) cDNA cloning of a novel CP3A from rat brain. Biochem. Biophys. Res. Commun. 221: 157-162.
25. Reeves, P. G., Nielson, F. H. & Fahey, G. C., Jr. (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123: 1939-1951.
26. Chipman, J. K., Kuruckgy, N. & Walker, C. H. (1978) The metabolism of dieldrin and two of its analogues: the relationship between rates of microsomal metabolism and rates of excretion of metabolites in the male rat. Biochem. Pharmacol. 28: 1337-1345.
27. Desjardins, J. P. & Iversen, P. L. (1995) Inhibition of rat cytochrome P450 3A2 by an antisense phosphorothioate oligodeoxynucleotide in vivo. J. Pharmacol. Exp. Ther. 275: 1608-1613.
28. Ma, F. & Lau, C. E. (1996) Determination of midazolam and its metabolites in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. J. Chromatogr. B. Biomed. Appl. 682: 109-113.
29. Ronis, M.J.J., Lumpkin, C. K., Ingelman-Sundberg, M. & Badger, T. M. (1991) Effects of short term ethanol and nutrition on the hepatic microsomal system in a model utilizing total enteral nutrition in the rat. AlcoholClin. Exp. Res. 15: 693-699.
30. Fang, N., Ronis, M.J.J., Hardy, H., Irby, D., Rowlands, J. C., Hakkak, R., Badger, T. M. (2002) Characterization of new medazolam metabolites by hepatic microsomes from dexamethasone-induced male rats by LC-MS/MS. FASEB J. 16: A244 (abs.).
31. Rowlands, J. C., Wang, H., Hakkak, R., Ronis, M.J.J., Strobel, H. W. & Badger, T. M. (2000) Chronic intragastric infusion of ethanol-containing diets induces CYP3a9 while decreasing CYP3A2 in male rats. J. Pharmacol. Exp. Ther. 295: 747-752.
32. Cimino, C., Ronis, M.J.J. Rowlands, J. C., Zhang, Z. & Badger, T. (2001) Analysis of plasma and urine isoflavone conjugates: Sequential enzymic digestion. FASEB J. 15: A985 (abs.).
33. Badger, T. M., Ronis, M.J.J. & Fang, N. (2003) The health effects of dietary isoflavones. In: Molecular Nutrition (Zemplini, J. & Daniel, H., eds.), pp. 201-217. CAB International, Wallingford, UK.
34. Hoey L., Rowland I. R., Lloyd, A. S., Clarke, D. B. & Wiseman, H. (2004) Influence of soya-based infant formula consumption on isoflavone and gut microflora metabolite concentrations in urine and on faecal microflora composition and metabolic activity in infants and children. Br. J. Nutr. 91: 607-616.
35. Pineau, T., Daujat, M., Pichard, L., Girard, F., Angevain, J., Bonfils, C. & Maurel, P. (1991) Developmental expression of rabbit cytochrome P450 CYPIA1, CYP1A2 and CYP3A6 genes. Effects of weaning and rifampicin. Eur. J. Biochem. 197: 145-153.
36. Treluyer, J. M., Bowers, G., Cazali, N., Sonnier, M., Rey, E., Pons, G. & Cresteil, T. (2003) Oxidative metabolism of amprenavir in the human liver. Effect of CYP3A maturation. Drug Metab. Disp. 31: 275-281.
37. Treluyer, J. M., Rey, E., Sonnier, M., Pons, G. & Cresteil, T. (2001) Evidence of impaired cisapride metabolism in neonates. Br. J. Clin. Pharmacol. 52: 419-425.
38. Xu, H., Harper, P. A., Kim, R. B., Kliewer, S. A., Lonnerdal, B. L. & Ito, S. (2004) Effects of human milk and formula on transcriptional regulation of cytochrome P450 3A4. FASEB J. 18: A1202 (abs.).
39. Li, Y. & Shay, N. F. (2004) Isoflavone-drug interactions in HepG2 cells and human hepatocytes. FASEB J. 18: A851 (abs.).
40. Tenenbaum, S. A., Carson, C. C., Larger, P. J. & Keene, J. D. (2000) Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl. Acad. Sci. U.S.A. 97: 14085-14090.
41. Zhang, Y., Lu, Z., Ku, L., Chen, Y. & Feng, Y. (2003) Tyrosine physphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J. 22: 1801-1810.
42. Goodwin, B., Redinbo, M. R. & Kliewer, S. A. (2002) Regulation of CYP3A gene transcription by the pregnane-X-receptor. Annu. Rev. Pharmacol. Toxicol. 42: 1-23.
43. Pascussi, J. M., Drocourt, L., Gerbal-Chaloin, S., Fabre, J. M., Maurel, P. & Vilarem, M. J. (2001) Dual effect of dexamethasone on CYP3a4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur. J. Biochem. 268: 6346-6358.
44. Zhang, W., Purchio, A., Chen, K., Burns, S. M., Contag, C. H. & Contag, P. R. (2003) In vivo activation of the human CYP3A4 promoter in mouse liver and regulation by pregnane X receptors. Biochem. Pharmacol. 65: 1889-18896.
45. Ronis, M.J.J., Ingelman-Sundberg, M. & Badger, T. M. (1994) Induction, inhibition and suppression of multiple hepatic cytochrome P450 isozymes in the male rat and bobwhite quail (Colinus virginianus) by ergosterol biosynthesis inhibiting fungicides (EIBFs). Biochem. Pharmacol. 48: 1953-1965.
46. Moore, L. B., Parks, D. J., Jones, S. A. Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B., Liddle, C., Blanchard, S. G., Wilson, T. M., Collins, J. L. & Kliewer, S. A. (2000) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275: 15122-15127.
47. Turan, V. K., Mishin, V. M. & Thomas, P. E. (2001) Clotrimazole is a selective and potent inhibitor of rat cytochrome P450 3A subfamily related testosterone metabolism. Drug Metab. Disp. 29: 837-842.
48. Jager, W., Sartori, M., Herzog, W. & Thalhammer, T. (1998) Genistein metabolism in liver microsomes of Wistar and mutant TR(-) rats. Res. Commun. Mol. Pathol. Pharmacol. 100: 105-116.
49. Roberts-Kirchoff, E. S., Crowley, J. R., Hollenberg, P. F. & Kim, H. (1999) Metabolism of genistein by rat and human cytochrome P450s. Chem. Res. Toxicol. 12: 610-616.
50. Ruckpaul, K. & Rein, H., eds. (1990) Principles, Mechanisms and Biological Consequences of Induction. Taylor & Francis, London, UK.
51. Badger, T. M., Ronis, M.J.J., Hakkak, R., Rowlands, J. C. & Korourian, S. (2002) The health consequences of early soy consumption. J. Nutr. 132: 559S-565S.
52. Olsen, A. K., Hansen, K. T. & Friis, C. (1997) Pig hepatocytes as an in vitro model to study the regulation of human CYP3A4: prediction of drug-drug interactions with 17-alpha ethinylestradiol. Chem.-Biol. Interact. 107: 93-108.
53. Badger, T. M., Ronis, M.J.J. & Hakkak, R. (2001) Developmental effects and health aspects of soy protein isolate, casein and whey in male and female rats. Int. J. Toxicol. 20: 165-174.